Dharan Infra-EPC Ltd
₹0.12
0 (0%)
Fri, 06 Nov 2026, 09:30 pm
Dharan Infra-EPC News
NCLT rejects Dharan Infra-EPC withdrawal plea
The NCLT Mumbai Bench dismissed Dharan Infra-EPC's application to withdraw its Corporate Insolvency Resolution Process. The company remains under IBC proceedings.
19 Oct 2026
companies
Promoters hold unencumbered shares in FY26
Promoters of Dharan Infra-EPC Limited confirmed no new encumbrance on shares for FY ended March 31, 2026.
14 Jul 2026
companies
Dharan Infra-EPC Independent Director Resigns
Mrs Prachi Aditya Sakpal resigns as Independent Director of Dharan Infra-EPC Limited with effect from May 8, 2026, citing personal commitments as the reason.
09 May 2026
companies
Dharan Infra-EPC Independent Director Resigns
Mrs Prachi Aditya Sakpal resigns as Independent Director of Dharan Infra-EPC Limited with effect from May 8, 2026, citing personal commitments as the reason.
08 May 2026
companies
Dharan Infra-EPC Independent Director Resigns
Mrs Prachi Aditya Sakpal resigns as Independent Director of Dharan Infra-EPC Limited with effect from May 8, 2026, citing personal commitments as the reason.
08 May 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo